As of 10:30 AM on the 29th, Peptron is trading at 20,700 KRW, down 6.76% from the previous day. This represents an 18.5% decline compared to June 24. Peptron is known as a bio company specializing in peptide pharmaceuticals.
Over the past 5 days, individual investors have net purchased 181,292 shares, while foreigners and institutions have net purchased 76,966 shares and net sold 133,546 shares, respectively.
On June 24, Peptron was a market topic due to a "sharp rise on news of a patent related to targeted anticancer drugs."
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
